Mark Johnson to Young Adult
This is a "connection" page, showing publications Mark Johnson has written about Young Adult.
Connection Strength
0.328
-
Bowers DC, Johnson MD. Feasibility of transcranial Doppler to evaluate vasculopathy among survivors of childhood brain tumors exposed to cranial radiation therapy. Pediatr Blood Cancer. 2025 Jan; 72(1):e31392.
Score: 0.118
-
Johnson MD, Ventre GJ, Kaye J, Patel HB, Naveed A, Prestigiacomo CJ, Ngwenya LB. Evaluating mortality and 6-month functional outcomes of patients with dural venous sinus thrombosis in traumatic brain injury. J Neurosurg. 2024 Jun 01; 140(6):1690-1699.
Score: 0.111
-
Rispens JR, Jones SA, Clemmons NS, Ahmed S, Harduar-Morano L, Johnson MD, Edge C, Vyas A, Bourgikos E, Orr MF. Anhydrous Ammonia Chemical Release - Lake County, Illinois, April 2019. MMWR Morb Mortal Wkly Rep. 2020 Jan 31; 69(4):109-113.
Score: 0.021
-
Arvold ND, Shi DD, Aizer AA, Norden AD, Reardon DA, Lee EQ, Nayak L, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Wen PY, Alexander BM. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol. 2017 Dec; 135(3):581-591.
Score: 0.018
-
Liu Y, Alexander BM, Chen YH, Horvath MC, Aizer AA, Claus EB, Dunn IF, Golby AJ, Johnson MD, Friesen S, Mannarino EG, Wagar M, Hacker FL, Arvold ND. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases. J Neurooncol. 2015 Sep; 124(3):429-37.
Score: 0.015
-
Rahman R, Catalano PJ, Reardon DA, Norden AD, Wen PY, Lee EQ, Nayak L, Beroukhim R, Dunn IF, Golby AJ, Johnson MD, Chiocca EA, Claus EB, Alexander BM, Arvold ND. Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation. J Neurooncol. 2015 Aug; 124(1):137-46.
Score: 0.015
-
Ramkissoon SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S, Knoff D, Dubuc A, Brown L, Burns M, Cryan JB, Abedalthagafi M, Kang YJ, Schultz N, Reardon DA, Lee EQ, Rinne ML, Norden AD, Nayak L, Ruland S, Doherty LM, LaFrankie DC, Horvath M, Aizer AA, Russo A, Arvold ND, Claus EB, Al-Mefty O, Johnson MD, Golby AJ, Dunn IF, Chiocca EA, Trippa L, Santagata S, Folkerth RD, Kantoff P, Rollins BJ, Lindeman NI, Wen PY, Ligon AH, Beroukhim R, Alexander BM, Ligon KL. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro Oncol. 2015 Oct; 17(10):1344-55.
Score: 0.015
-
Mamidi RN, Cuyckens F, Chen J, Scheers E, Kalamaridis D, Lin R, Silva J, Sha S, Evans DC, Kelley MF, Devineni D, Johnson MD, Lim HK. Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans. Drug Metab Dispos. 2014 May; 42(5):903-16.
Score: 0.014